Sanochemia Pharmazeutika competitorsClear all

Sanochemia Pharmazeutika's top competitors include Lava Therapeutics, Cellis and Cellectar Biosciences.
Sanochemia Pharmazeutika
Sanochemia Pharmazeutika
Sanochemia Pharmazeutika is a specialty pharmaceuticals company, which develops and manufactures drugs and diagnostics in the areas of neurodegeneration, pain, and oncology.
Lava Therapeutics
Lava Therapeutics
Lava Therapeutics is a biotech company which develops proprietary T-cell engagers.
Cellis
Cellis
Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology.
Cellectar Biosciences
Cellectar Biosciences
Cellectar Biosciences is a clinical stage biopharmaceutical company that engages in the development of targeted phospholipid drug conjugates for the treatment and imaging of cancer.
Founding Date
Founding Date
1990
Founding Date
2016
Founding Date
2015
Founding Date
1996
Type
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Wien, AT HQ
Neufeld An Der Leitha, AT
Neuss, DE
Zug, CH
City Of Bristol, GB
Charlotte, US
Locations
's-Hertogenbosch, NL HQ
Locations
Zürich, CH HQ
Warszawa, PL
Locations
Madison, US HQ
Florham Park, US
Employees
Employees
152
Employees
4
Employees
814% increase
Employees
753% decrease
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
446649
Alexa Website Rank
N/A
Alexa Website Rank
301103
For sources of this data, please see the company profile

View company profiles

Lava Therapeutics
HQ
's-Hertogenbosch, NL
Employees
4

Lava Therapeutics is a biotech company which develops proprietary T-cell engagers.

View company
Cellis
HQ
Zürich, CH
Employees
8↑ 14% increase

Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology.

View company
Cellectar Biosciences
HQ
Madison, US
Employees
7

Cellectar Biosciences is a clinical stage biopharmaceutical company that engages in the development of targeted phospholipid drug conjugates for the treatment and imaging of cancer.

View company